Amplimexon imexon: Phase Ib/II start

AmpliMed began the open-label, dose-escalation, U.S. Phase Ib portion of a Phase Ib/II trial with Amplimexon as a monotherapy in 40-50 previously treated MM patients. The trial will continue into the ...